AVEO - .7278 Pre-market now at 1.22/1.23 AVEO Oncology Announces Positive CHMP Opinion for Tivozanib as a Treatment of Advanced Renal Cell Carcinoma http://stockcharts.com/c-sc/sc?s=AVEO&p=D&b=5&g=0&i=t51995615480&r=1498220509757 http://stockcharts.com/c-sc/sc?s=AVEO&p=W&b=5&g=0&i=t77062731832&r=1498220494586